Watchlist Price Alert

Drugs Made In America Acq... (DMAA)

NASDAQ: DMAA · Real-Time Price · USD

10.11

0.01 (0.10%)

At close: May 07, 2025, 9:30 AM

Drugs Made In America Acquisition Ordinary Shares Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024
Period Ending	Dec 31, 2024
Net Income	-479.73
Depreciation & Amortization	n/a
Stock-Based Compensation	n/a
Other Working Capital	132.48
Other Non-Cash Items	51.94
Deferred Income Tax	n/a
Change in Working Capital	132.48
Operating Cash Flow	-295.31
Capital Expenditures	n/a
Cash Acquisitions	n/a
Purchase of Investments	n/a
Sales Maturities Of Investments	n/a
Other Investing Acitivies	n/a
Investing Cash Flow	n/a
Debt Repayment	n/a
Common Stock Repurchased	n/a
Dividend Paid	n/a
Other Financial Acitivies	173.62K
Financial Cash Flow	173.62K
Net Cash Flow	n/a
Free Cash Flow	-295.31